08-31-2023
INR/share | |
Price | 5,607.85 |
Dividend | 39.82 |
Earnings | 295.15 |
Cash-flow | 348.31 |
Book value | 1,401.96 |
Equity | 1,266.74 |
Dr Reddys Labs is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Dr Reddys Labs is a company from India, and his stocks are publicly traded.
Dr Reddys Labs stock dividend
Dr Reddys Labs paid a total dividend of 6,610 million INR last year, for a market value of 930,903 millions (Market Cap 678,101 millions). Dr Reddys Labs dividend per share is 39.82 INR, and his stock market price 5,607.85 INR.
According to the chart below, where dividend yield is displayed, Dr Reddys Labs has a dividend yield of 0.71%, lower than the amount offered by both the market average and companies from India. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Dr Reddys Labs stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high India dividend stocks list.
Dr Reddys Labs Dividend Payout
About the ability of Dr Reddys Labs to maintain his current dividend of INR 39.82 per share, an amount that accounts for 0.71%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Dr Reddys Labs payout on ernings is currently 13.49%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that Dr Reddys Labscan maintain his current dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Dr Reddys Labs is INR 348.31 per share, which is higher than the dividend per share paid by the company of INR 39.82, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Dr Reddys Labs, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Dr Reddys Labs Dividend History
Below you will find a table with the historical evolution of Dr Reddys Labs's dividend stock, both in percentage and in INR, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | INR | Paypout | Shares* |
Present | 0.71% | 39.82 | 13.49% | 166 |
2022 | 0.71% | 30.09 | 18.32% | 166 |
2021 | 0.51% | 25.03 | 19.28% | 166 |
2020 | 0.48% | 24.98 | 17.76% | 166 |
2019 | 0.70% | 20.12 | 14.77% | 166 |
2018 | 0.76% | 19.89 | 22.73% | 166 |
2017 | 0.83% | 20.04 | 21.08% | 166 |
2016 | 0.63% | 20.14 | 14.55% | 170 |
2015 | 0.64% | 19.89 | 13.76% | 170 |
*In millions
Then you can see the evolution of Dr Reddys Labs dividend stock, and compare it with the average of India stocks and that of the Pharmaceuticals and Biotechnology stocks.
Dr Reddys Labs Stock performance
Finally, last moth Dr Reddys Labs showed a return of -0.60% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 32.10% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.